MEP38708A - Use of hcg and lh in controlled ovarian hyperstimulation - Google Patents
Use of hcg and lh in controlled ovarian hyperstimulationInfo
- Publication number
- MEP38708A MEP38708A MEP-387/08A MEP38708A MEP38708A ME P38708 A MEP38708 A ME P38708A ME P38708 A MEP38708 A ME P38708A ME P38708 A MEP38708 A ME P38708A
- Authority
- ME
- Montenegro
- Prior art keywords
- hcg
- ovarian hyperstimulation
- controlled ovarian
- rates
- decreased
- Prior art date
Links
- 206010033266 Ovarian Hyperstimulation Syndrome Diseases 0.000 title 1
- 206010000210 abortion Diseases 0.000 abstract 1
- 231100000176 abortion Toxicity 0.000 abstract 1
- 230000003247 decreasing effect Effects 0.000 abstract 1
- 230000032692 embryo implantation Effects 0.000 abstract 1
- 230000011599 ovarian follicle development Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/06—Antiabortive agents; Labour repressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S930/00—Peptide or protein sequence
- Y10S930/01—Peptide or protein sequence
- Y10S930/11—Gonadotropin; related peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S930/00—Peptide or protein sequence
- Y10S930/01—Peptide or protein sequence
- Y10S930/13—Luteinizing hormone-releasing hormone; related peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Endocrinology (AREA)
- Veterinary Medicine (AREA)
- Reproductive Health (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Diabetes (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP01307758 | 2001-09-12 | ||
PCT/GB2002/004167 WO2003022303A2 (en) | 2001-09-12 | 2002-09-12 | Use of hcg and lh in controlled ovarian hyperstimulation |
Publications (1)
Publication Number | Publication Date |
---|---|
MEP38708A true MEP38708A (en) | 2011-02-10 |
Family
ID=8182262
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MEP-387/08A MEP38708A (en) | 2001-09-12 | 2002-09-12 | Use of hcg and lh in controlled ovarian hyperstimulation |
Country Status (27)
Country | Link |
---|---|
US (1) | US7402558B2 (no) |
EP (1) | EP1425033B1 (no) |
JP (1) | JP2005501919A (no) |
KR (1) | KR20040032952A (no) |
CN (1) | CN100376289C (no) |
AR (1) | AR036593A1 (no) |
AT (1) | ATE489964T1 (no) |
BR (1) | BR0212447A (no) |
CA (1) | CA2457851A1 (no) |
CY (1) | CY1110991T1 (no) |
DE (1) | DE60238490D1 (no) |
DK (1) | DK1425033T3 (no) |
EA (1) | EA009279B1 (no) |
ES (1) | ES2356895T3 (no) |
HK (1) | HK1067865A1 (no) |
HR (1) | HRP20040086A2 (no) |
IL (1) | IL160782A0 (no) |
ME (1) | MEP38708A (no) |
MX (1) | MXPA04002257A (no) |
NO (1) | NO327153B1 (no) |
PL (1) | PL369021A1 (no) |
PT (1) | PT1425033E (no) |
SI (1) | SI1425033T1 (no) |
UA (1) | UA82052C2 (no) |
WO (1) | WO2003022303A2 (no) |
YU (1) | YU21104A (no) |
ZA (1) | ZA200400781B (no) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040248784A1 (en) | 2003-06-03 | 2004-12-09 | Marco Filicori | Unitary combinations of FSH and hCG |
GB0723882D0 (en) * | 2007-12-07 | 2008-01-23 | Univ Leicester | Methods for the detection of a threatened miscarriage |
EP2734239A2 (en) | 2011-07-18 | 2014-05-28 | Arts Biologics A/S | Long acting luteinizing hormone (lh) compound |
US20160024181A1 (en) | 2013-03-13 | 2016-01-28 | Moderna Therapeutics, Inc. | Long-lived polynucleotide molecules |
ES2716862T3 (es) * | 2014-12-22 | 2019-06-17 | Ferring Bv | Terapia con antagonistas del receptor de oxitocina en la fase lútea para la implantación y embarazo en mujeres que se someten a tecnologías de reproducción asistida |
SG11201706693QA (en) * | 2015-02-26 | 2017-09-28 | Ferring Bv | Methods of treating infertility |
US11185569B2 (en) * | 2016-05-04 | 2021-11-30 | University Of Cincinnati | ActRIIB:Fc to treat infertility in females |
MX2021004383A (es) * | 2018-10-17 | 2021-06-04 | Ferring Bv | Composiciones y metodos para la estimulacion ovarica controlada. |
CN110041436A (zh) * | 2019-04-28 | 2019-07-23 | 广州威生医药科技有限公司 | 长效重组fsh融合蛋白在母猪批次化生产中的应用 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4589402A (en) | 1984-07-26 | 1986-05-20 | Serono Laboratories, Inc. | Method of in vitro fertilization |
US5705478A (en) * | 1989-02-21 | 1998-01-06 | Washington University | Covalently linked β subunits of the glycoprotein hormones as antagonists |
FR2744367B1 (fr) * | 1996-02-02 | 1999-07-09 | Emperaire Jean Claude | Medicaments pour le declenchement de l'ovulation |
DE69831241T2 (de) * | 1997-06-20 | 2006-03-23 | Akzo Nobel N.V. | Gonadotropin freisetzendes Hormon Antagonist |
ZA987497B (en) * | 1997-09-08 | 1999-02-23 | Akzo Nobel Nv | Expression of gonadotropins in dictyostelium |
US6090848A (en) * | 1997-12-01 | 2000-07-18 | Sigma-Tau Healthscience S.P.A. | Compositions and methods for increasing the concentration and/or motility of spermatozoa in humans |
ES2258445T3 (es) * | 1999-02-24 | 2006-09-01 | Novo Nordisk A/S | Metodo in vitro para la sincronizacion de la maduracion de ovocitos. |
EP1176976B2 (en) * | 1999-05-07 | 2015-10-21 | Laboratoires Serono SA | Use of lh administered in mid- or late-follicular phase for the treatment of anovulatory women |
RS50805B (sr) * | 2000-01-27 | 2010-08-31 | Laboratoires Serono Sa. | Upotreba fsh za lečenje neplodnosti |
US6953774B2 (en) * | 2000-08-11 | 2005-10-11 | Applied Research Systems Ars Holding N.V. | Methods of inducing ovulation |
-
2002
- 2002-09-12 IL IL16078202A patent/IL160782A0/xx unknown
- 2002-09-12 AR ARP020103457A patent/AR036593A1/es unknown
- 2002-09-12 SI SI200230927T patent/SI1425033T1/sl unknown
- 2002-09-12 MX MXPA04002257A patent/MXPA04002257A/es not_active Application Discontinuation
- 2002-09-12 JP JP2003526431A patent/JP2005501919A/ja not_active Withdrawn
- 2002-09-12 KR KR10-2004-7002588A patent/KR20040032952A/ko not_active Application Discontinuation
- 2002-09-12 AT AT02758602T patent/ATE489964T1/de active
- 2002-09-12 EA EA200400426A patent/EA009279B1/ru not_active IP Right Cessation
- 2002-09-12 EP EP02758602A patent/EP1425033B1/en not_active Revoked
- 2002-09-12 ME MEP-387/08A patent/MEP38708A/xx unknown
- 2002-09-12 CN CNB028175751A patent/CN100376289C/zh not_active Expired - Fee Related
- 2002-09-12 US US10/489,412 patent/US7402558B2/en not_active Expired - Fee Related
- 2002-09-12 PL PL02369021A patent/PL369021A1/xx not_active Application Discontinuation
- 2002-09-12 ES ES02758602T patent/ES2356895T3/es not_active Expired - Lifetime
- 2002-09-12 YU YU21104A patent/YU21104A/sh unknown
- 2002-09-12 BR BR0212447-5A patent/BR0212447A/pt not_active IP Right Cessation
- 2002-09-12 WO PCT/GB2002/004167 patent/WO2003022303A2/en active Application Filing
- 2002-09-12 DE DE60238490T patent/DE60238490D1/de not_active Expired - Lifetime
- 2002-09-12 CA CA002457851A patent/CA2457851A1/en not_active Abandoned
- 2002-09-12 PT PT02758602T patent/PT1425033E/pt unknown
- 2002-09-12 DK DK02758602.3T patent/DK1425033T3/da active
- 2002-12-09 UA UA2004031859A patent/UA82052C2/uk unknown
-
2004
- 2004-01-28 HR HRP20040086 patent/HRP20040086A2/xx not_active Application Discontinuation
- 2004-01-30 ZA ZA2004/00781A patent/ZA200400781B/en unknown
- 2004-03-05 NO NO20040962A patent/NO327153B1/no not_active IP Right Cessation
-
2005
- 2005-02-22 HK HK05101452A patent/HK1067865A1/xx not_active IP Right Cessation
-
2010
- 2010-12-15 CY CY20101101156T patent/CY1110991T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
UA82052C2 (uk) | 2008-03-11 |
NO327153B1 (no) | 2009-05-04 |
EP1425033B1 (en) | 2010-12-01 |
SI1425033T1 (sl) | 2011-01-31 |
CN1553810A (zh) | 2004-12-08 |
AR036593A1 (es) | 2004-09-22 |
IL160782A0 (en) | 2004-08-31 |
CN100376289C (zh) | 2008-03-26 |
BR0212447A (pt) | 2004-08-17 |
EP1425033A2 (en) | 2004-06-09 |
ATE489964T1 (de) | 2010-12-15 |
DE60238490D1 (de) | 2011-01-13 |
US20050020489A1 (en) | 2005-01-27 |
ZA200400781B (en) | 2005-04-26 |
ES2356895T3 (es) | 2011-04-14 |
JP2005501919A (ja) | 2005-01-20 |
WO2003022303A2 (en) | 2003-03-20 |
YU21104A (sh) | 2006-08-17 |
NO20040962L (no) | 2004-03-05 |
KR20040032952A (ko) | 2004-04-17 |
MXPA04002257A (es) | 2004-07-23 |
US7402558B2 (en) | 2008-07-22 |
HK1067865A1 (en) | 2005-04-22 |
CA2457851A1 (en) | 2003-03-20 |
CY1110991T1 (el) | 2015-06-11 |
EA009279B1 (ru) | 2007-12-28 |
HRP20040086A2 (en) | 2004-12-31 |
WO2003022303A3 (en) | 2003-12-18 |
DK1425033T3 (da) | 2011-01-10 |
PL369021A1 (en) | 2005-04-18 |
EA200400426A1 (ru) | 2004-08-26 |
PT1425033E (pt) | 2010-12-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MEP39208A (en) | USE OF hCG IN CONTROLLED OVARIAN HYPERSTIMULATION | |
SE0100901D0 (sv) | New composition | |
BR0215405A (pt) | Composições e processos de uso de collajolie | |
HK1067865A1 (en) | Use of hcg and lh in controlled ovarian hyperstimulation | |
YU17003A (sh) | Spiroheterociklični nitrili upotrebljivi kao reverzibilni inhibitori cisteinskih proteaza | |
CY2014038I2 (el) | Αντι-il-6 αντισωματα, συνθεσεις, μεθοδοι και χρησεις | |
PA8565101A1 (es) | Formas de dosificacion farmaceutica de liberacion controlada de un inhibidor de la proteina de transferencia de ester de colesterilo | |
IL156774A0 (en) | Inhibitors of cruzipain and other cysteine proteases | |
CY1112957T1 (el) | Μη νευροτοξικοι παραγοντες, οι οποιοι ενεργοποιουν το πλασμινογονο για τη θεραπευτικη αγωγη εγκεφαλικου επεισοδιου | |
DK1262236T3 (da) | Fremgangsmåde til fremstilling af formet legeme af alfa-alumina | |
DK1383742T3 (da) | Syntese og fremgangsmåder til anvendelse af tetrahydroindolonanaloge og derivater | |
ATE292966T1 (de) | Methode zur synthetisierung von leflunomid | |
ES2218407T3 (es) | Uso de oxazolidinonas tiamida para el tratamiento de la resorcion osea y la osteoporosis. | |
ATE277924T1 (de) | Aryl-8-azabicyclo(3.2.1)octanes für die behandlung von depression | |
BR0117078B1 (pt) | mÉtodo para preparaÇço de couro utilizando protease e mÉtodo para tratamento de dejetos derivados do processamento do couro utilizando o mesmo. | |
WO2002032884A3 (en) | Methods for the preparation of biphenyl isoxazole sulfonamides | |
SE0100374D0 (sv) | Novel compositions of potassium channel openers and protein kinase c inhibitors and use thereof | |
WO2002057248A3 (en) | Inhibitors of cruzipain and other cysteine proteases | |
ATA9412000A (de) | Einrichtung, insbesondere brenner zur erzeugung von plasma | |
SE0101242D0 (sv) | Penna | |
MXPA01009174A (es) | Antagonistas de endotelina novedosos derivados de piridazina. | |
DK1438341T3 (da) | Antistoffer som stimulerer produktionen af IL-1Ra | |
ZA200102866B (en) | Treatment of phospho gypsum. | |
BR0104878B1 (pt) | vaporizador direcional de uso humano. | |
BR8002856U (pt) | Televisão relógio |